Jefferies Financial Group Inc. Blueprint Medicines Corp Put Options Transaction History

Jefferies Financial Group Inc.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 13, 2024	SELL	$73.17 - $99.79 $204,876 - $279,412	-2,800 Reduced 24.78%	8,500 $806,000
Q4 2023 Feb 13, 2024	SELL	$43.96 - $92.84 $487,956 - $1.03 Million	-11,100 Reduced 49.55%	11,300 $1.04 Million
Q2 2023 Aug 14, 2023	BUY	$42.2 - $66.37 $476,860 - $749,981	11,300 Added 101.8%	22,400 $1.42 Million
Q4 2022 Sep 21, 2023	SELL	$41.06 - $66.48 $463,978 - $751,224	-11,300 Reduced 50.45%	11,100 $486,000
Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $455,766 - $737,928	11,100 New	11,100 $486,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.